DNA
Price
$9.98
Change
-$0.81 (-7.51%)
Updated
Jul 11 closing price
Capitalization
584.15M
IMUX
Price
$0.83
Change
-$0.01 (-1.19%)
Updated
Jul 11 closing price
Capitalization
79.54M
25 days until earnings call
Interact to see
Advertisement

DNA vs IMUX

Header iconDNA vs IMUX Comparison
Open Charts DNA vs IMUXBanner chart's image
Ginkgo Bioworks Holdings
Price$9.98
Change-$0.81 (-7.51%)
Volume$1.54M
Capitalization584.15M
Immunic
Price$0.83
Change-$0.01 (-1.19%)
Volume$442.45K
Capitalization79.54M
DNA vs IMUX Comparison Chart in %
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNA vs. IMUX commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Hold and IMUX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2025
Stock price -- (DNA: $9.98 vs. IMUX: $0.83)
Brand notoriety: DNA and IMUX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 120% vs. IMUX: 24%
Market capitalization -- DNA: $584.15M vs. IMUX: $79.54M
DNA [@Biotechnology] is valued at $584.15M. IMUX’s [@Biotechnology] market capitalization is $79.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileIMUX’s FA Score has 0 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • IMUX’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNA and IMUX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 3 TA indicator(s) are bullish while IMUX’s TA Score has 3 bullish TA indicator(s).

  • DNA’s TA Score: 3 bullish, 5 bearish.
  • IMUX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, IMUX is a better buy in the short-term than DNA.

Price Growth

DNA (@Biotechnology) experienced а -21.54% price change this week, while IMUX (@Biotechnology) price change was +14.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.14%. For the same industry, the average monthly price growth was +16.46%, and the average quarterly price growth was +20.75%.

Reported Earning Dates

DNA is expected to report earnings on May 06, 2025.

IMUX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($584M) has a higher market cap than IMUX($79.5M). DNA YTD gains are higher at: 1.629 vs. IMUX (-16.990). IMUX has higher annual earnings (EBITDA): -100.85M vs. DNA (-387.59M). DNA has more cash in the bank: 517M vs. IMUX (14.3M). IMUX has less debt than DNA: IMUX (975K) vs DNA (435M). DNA has higher revenues than IMUX: DNA (237M) vs IMUX (0).
DNAIMUXDNA / IMUX
Capitalization584M79.5M735%
EBITDA-387.59M-100.85M384%
Gain YTD1.629-16.990-10%
P/E RatioN/AN/A-
Revenue237M0-
Total Cash517M14.3M3,615%
Total Debt435M975K44,615%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNAIMUX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCECX33.67-0.04
-0.12%
Fidelity Advisor Consumer Discret C
MDVWX7.91-0.04
-0.50%
Manning & Napier Disciplined Value W
GONCX30.40-0.24
-0.78%
JHancock International Growth C
RRSVX15.22-0.13
-0.85%
RBC Small Cap Value R6
VWYGX40.50-0.36
-0.88%
Voya Small Cap Growth C